A. Abot, C. Fontaine, I. Raymond-letron, G. Flouriot, M. Adlanmerini et al., , p.325

H. Berges, H. Laurell, P. Gourdy, F. Lenfant, and J. F. Arnal, The AF-1 activation 326 function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell 327 proliferation in vivo, Endocrinology, vol.154, pp.2222-2255, 2013.

D. L. Ahlbory-dieker, B. D. Stride, G. Leder, and J. Schkoldow,

A. Sommer, M. G. Parker, G. Schutz, and T. M. Wintermantel, DNA binding by estrogen 330 receptor-alpha is essential for the transcriptional response to estrogen in the liver and the 331 uterus, Mol Endocrinol, vol.23, pp.1544-55, 2009.

A. Del-barrio, J. L. Zarif, M. De-miguel, M. P. Azaar, A. Makdissy et al.,

F. Arnalich and J. L. Alio, Cellular Therapy With Human Autologous Adipose-Derived 334, 2017.

, Adult Stem Cells for Advanced Keratoconus Cornea, p.335

G. L. Anderson, M. Limacher, A. R. Assaf, T. Bassford, S. A. Beresford et al.,

B. V. Howard, J. Hsia, A. Hubbell, R. Jackson, K. C. Johnson et al.,

J. Ockene, M. J. O-'sullivan, L. Phillips, R. L. Prentice, C. Ritenbaugh et al., , p.341

S. Wassertheil-smoller, Effects of conjugated equine estrogen in postmenopausal 342 women with hysterectomy: the Women's Health Initiative randomized controlled trial, Jama, vol.343, pp.291-1701, 2004.

J. Barrera, K. L. Chambliss, M. Ahmed, K. Tanigaki, B. Thompson et al., , p.345

P. W. Shaul, Bazedoxifene and conjugated estrogen prevent diet-induced obesity, 346 hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract, Am J, p.347, 2014.

, Physiol Endocrinol Metab, vol.307, pp.345-54

T. J. Berrodin, K. C. Chang, B. S. Komm, L. P. Freedman, and S. Nagpal, Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination, Molecular Endocrinology, vol.23, issue.1, pp.74-85, 2009.
DOI : 10.1210/me.2008-0366

D. R. Boverhof, K. C. Fertuck, L. D. Burgoon, J. E. Eckel, C. Gennings et al., 352 Temporal-and dose-dependent hepatic gene expression changes in immature 353 ovariectomized mice following exposure to ethynyl estradiol, Carcinogenesis, pp.1277-1291, 2004.

K. C. Chang, Y. Wang, P. V. Bodine, S. Nagpal, and B. S. Komm, Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: Insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens, The Journal of Steroid Biochemistry and Molecular Biology, vol.118, issue.1-2, pp.117-141, 2010.
DOI : 10.1016/j.jsbmb.2009.11.003

R. T. Chlebowski, S. L. Hendrix, R. D. Langer, M. L. Stefanick, M. Gass et al., , p.359

M. A. Gilligan, M. G. Cyr, C. A. Thomson, J. Khandekar, H. Petrovitch et al., Influence of estrogen plus progestin on breast cancer and mammography in healthy 361 postmenopausal women: the Women's Health Initiative Randomized Trial, JAMA, vol.360, issue.289, pp.3243-362, 2003.

D. Torre, S. Biserni, A. Rando, G. Monteleone, G. Ciana et al., The Conundrum of Estrogen Receptor Oscillatory Activity in the Search for an Appropriate Hormone Replacement Therapy, Endocrinology, vol.152, issue.6, pp.2256-65, 2011.
DOI : 10.1210/en.2011-0173

R. Fontana, S. Della-torre, C. Meda, A. Longo, C. Eva et al., Estrogen replacement 367 therapy regulation of energy metabolism in female mouse hypothalamus, Endocrinology, pp.368-2213, 2014.
DOI : 10.1210/en.2013-1731
URL : https://academic.oup.com/endo/article-pdf/155/6/2213/10826098/endo2213.pdf

H. Gao, S. Falt, A. Sandelin, J. A. Gustafsson, and K. Dahlman-wright, Genome-Wide Identification of Estrogen Receptor ??-Binding Sites in Mouse Liver, Molecular Endocrinology, vol.22, issue.1, pp.10-371, 2008.
DOI : 10.1210/me.2007-0121
URL : https://academic.oup.com/mend/article-pdf/22/1/10/8936765/mend0010.pdf

T. Goldberg and B. Fidler, Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for 373 the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause 374, 2015.

, And the Prevention of Postmenopausal Osteoporosis, P T, pp.178-82

F. K. Gordon, C. S. Vallaster, T. Westerling, L. K. Iyer, M. Brown et al., Research 376 resource: Aorta-and liver-specific ERalpha-binding patterns and gene regulation by estrogen, p.377, 2014.

, Mol Endocrinol, vol.28, pp.1337-51

S. J. Han, K. Begum, C. E. Foulds, R. A. Hamilton, S. Bailey et al.,

, Selective Estrogen Complex for Endometrial and Breast Safety Mol Pharmacol, vol.89, pp.14-26

S. Handgraaf, E. Riant, A. Fabre, A. Waget, R. Burcelin et al., Prevention of obesity and insulin resistance by estrogens requires 383 ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable, Diabetes, pp.384-4098, 2013.

A. Hurtado, K. A. Holmes, C. S. Ross-innes, D. Schmidt, and J. S. Carroll, FOXA1 is a key determinant of estrogen receptor function and endocrine response, Nature Genetics, vol.14, issue.1, pp.27-33, 2011.
DOI : 10.1016/j.cell.2006.05.052

R. Kagan, R. S. Williams, K. Pan, S. Mirkin, and J. H. Pickar, A randomized, placebo-and active- 388 controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe 389 vulvar/vaginal atrophy in postmenopausal women, pp.281-290, 2010.

J. H. Kim, M. S. Meyers, S. S. Khuder, S. L. Abdallah, H. T. Muturi et al., , p.391

S. M. Najjar, C. Leloup, and F. Mauvais-jarvis, Tissue-selective estrogen complexes 392 with bazedoxifene prevent metabolic dysfunction in female mice, pp.177-90, 2014.

H. Kobayashi, S. Yoshida, Y. J. Sun, N. Shirasawa, and A. Naito, Gastric estradiol-17?? (E2) and liver ER?? correlate with serum E2 in the cholestatic male rat, Journal of Endocrinology, vol.301, issue.6, pp.39-395, 2013.
DOI : 10.1152/ajpgi.00061.2011

B. S. Komm and S. Mirkin, Evolution of the tissue selective estrogen complex (TSEC), J Cell 397 Physiol, pp.1423-1430, 2013.

S. Liu, S. J. Han, and C. L. Smith, Cooperative activation of gene expression by agonists and 399 antagonists mediated by estrogen receptor heteroligand dimer complexes, Mol Pharmacol, vol.400, issue.83, pp.1066-77, 2013.

R. A. Lobo, J. V. Pinkerton, M. L. Gass, M. H. Dorin, S. Ronkin et al., Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile, Fertility and Sterility, vol.92, issue.3, pp.1025-1063, 2009.
DOI : 10.1016/j.fertnstert.2009.03.113

S. Mirkin and B. S. Komm, Tissue-selective estrogen complexes for postmenopausal women, Maturitas, vol.76, issue.3, pp.213-233, 0406.
DOI : 10.1016/j.maturitas.2013.06.003

H. Mohammed, C. Santos, A. A. Serandour, H. R. Ali, G. D. Brown et al., Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor, Cell Reports, vol.3, issue.2, pp.342-351
DOI : 10.1016/j.celrep.2013.01.010
URL : https://doi.org/10.1016/j.celrep.2013.01.010

H. Naqvi, S. Sakr, T. Presti, G. Krikun, B. Komm et al., Treatment with 412 bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine 413 model, Biol Reprod, vol.90, issue.121, p.414, 2014.

P. Oliva, C. Roncoroni, E. Radaelli, E. Brunialti, N. Rizzi et al., , p.415

P. Ciana, B. Komm, and A. Maggi, Global profiling of TSEC proliferative potential by 416 the use of a reporter mouse for proliferation, Reprod Sci, vol.20, pp.119-147, 2013.

S. Palacios, S. L. Silverman, T. J. De-villiers, A. B. Levine, S. Goemaere et al., A 7-year 419 randomized, placebo-controlled trial assessing the long-term efficacy and safety of 420 bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and 421 fracture, Menopause. 22, 806-13. 422 SUPPLEMENTARY TABLE LEGEND Supplementary Table 1: Summary of BZA and CE doses used to study TSEC effect in vivo in mice with corresponding references Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice, Mol Metab, vol.3, pp.177-190, 2014.

@. Barrera, J. Chambliss, K. Ahmed, M. Tanigaki, K. Thompson et al., Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract, American Journal of Physiology-Endocrinology and Metabolism, vol.131, issue.3, pp.345-354, 2014.
DOI : 10.1074/jbc.M110.147850

@. Peano, B. Crabtree, J. Komm, B. Winneker, R. Harris et al., Effects of Various Selective Estrogen Receptor Modulators with or without Conjugated Estrogens on Mouse Mammary Gland, Endocrinology, vol.150, issue.4, pp.1897-1903, 2009.
DOI : 10.1210/en.2008-1210

@. Song, Y. Santen, R. Wang, J. Yue, and W. , Effects of the Conjugated Equine Estrogen/Bazedoxifene Tissue-Selective Estrogen Complex (TSEC) on Mammary Gland and Breast Cancer in Mice, Endocrinology, vol.153, issue.12, pp.5706-5715, 2012.
DOI : 10.1210/en.2012-1583

@. Della-torre, S. Biserni, A. Rando, G. Monteleone, G. Ciana et al., The Conundrum of Estrogen Receptor Oscillatory Activity in the Search for an Appropriate Hormone Replacement Therapy, Endocrinology, vol.152, issue.6, pp.2256-2265, 2011.
DOI : 10.1210/en.2011-0173

@. Oliva, P. Roncoroni, C. Radaelli, E. Brunialti, E. Rizzi et al., Global profiling of tsec proliferative potential by the use of a reporter mouse for proliferation. Reproductive sciences, pp.119-128, 2013.

@. Naqvi, H. Sakr, S. Presti, T. Krikun, G. Komm et al., Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model, Biology of reproduction, vol.90, p.121, 2014.

@. Fontana, R. , D. Torre, S. Meda, C. Longo et al., Estrogen Replacement Therapy Regulation Of Energy Metabolism In Female Mouse Hypothalamus, Endocrinology, vol.155, issue.6, pp.2213-2221, 2014.
DOI : 10.1210/en.2013-1731

, Supplementary Table 2 : List of specific primers used in the study Supplementary Table 3: Effect of the acute administration of E2 and BZA alone or in combination on liver mRNA levels

A. Fabre, R. Solinhac, L. Peron, C. Avner, S. Lenfant et al., E2 (10 mg/kg) and/or BZA (2 or 10 mg/kg) Gene regulation was then analyzed using extracted liver RNA by 96.96 Dynamic Arrays. Significant fold gene regulation (>1.5 fold) are red highlighted. Gene involved in the regulation of metabolic pathway are yellow highlighted, Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute e2 treatment. Molecular endocrinology, pp.709-732, 2016.

@. Gao, H. Falt, S. Sandelin, A. Gustafsson, J. Dahlman-wright et al., Genome-Wide Identification of Estrogen Receptor ??-Binding Sites in Mouse Liver, Molecular Endocrinology, vol.22, issue.1, pp.10-22, 2008.
DOI : 10.1210/me.2007-0121

@. Boverhof, D. Fertuck, K. Burgoon, L. Eckel, J. Gennings et al., Temporal-and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus, Carcinogenesis. Molecular endocrinology, vol.2523, pp.1277-1291, 2004.

@. Ahlbory-dieker, D. Stride, B. Leder, G. Schkoldow, J. Trolenberg et al., DNA Binding by Estrogen Receptor-?? Is Essential for the Transcriptional Response to Estrogen in the Liver and the Uterus, Molecular Endocrinology, vol.23, issue.10, pp.1544-1555, 2009.
DOI : 10.1210/me.2009-0045

G. @bullet-palierne, A. Fabre, R. Solinhac, L. Peron, C. Avner et al., BZA (10mg/kg) alone or in combination on liver mRNA levels. Four-week-old ovariectomized mice received an oral administration of vehicle (PBS containing 0.5% methylcellulose 2% Tween 80 and 5% DMSO), CE (10 mg/kg) and/or BZA (10 mg/kg) Gene regulation was then analyzed using extracted liver RNA by 96.96 Dynamic Arrays. Significant fold gene regulation (>1.5 fold) are red highlighted. Genes involved in the regulation of metabolic pathway are yellow highlighted, Metivier R. Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute e2 treatment. Molecular endocrinology, pp.709-732, 2016.

, Effect of chronic administration of CE (10 mg/kg) and BZA (10mg/kg) alone or in combination on liver mRNA levels. Four-week-old ovariectomized C57Bl/6J mice were chronically treated (3 weeks) with BZA (10 mg, Supplementary Table CE, vol.5

A. Fabre, R. Solinhac, L. Peron, C. Avner, S. Lenfant et al., Significant fold gene regulation induced by the different treatments are reported in the Table. (A) Red highlight represents up-(>1.5 fold) regulated genes and (B) Green highlight down-(<0.65 fold) regulated genes. Genes involved in the regulation of metabolic pathway are yellow highlighted Changes in gene expression and estrogen receptor cistrome in mouse liver upon acute e2 treatment, Gene regulation was then analyzed using extracted liver RNA by 96.96 Dynamic Arrays, pp.709-732, 2016.

@. Gordon, F. Vallaster, C. Westerling, T. Iyer, L. Brown et al., Research Resource: Aorta- and Liver-Specific ER??-Binding Patterns and Gene Regulation by Estrogen, Molecular Endocrinology, vol.28, issue.8, pp.1337-1351, 2014.
DOI : 10.1210/me.2013-1395

@. Kim, J. Meyers, M. Khuder, S. Abdallah, S. Muturi et al., Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice, Molecular Metabolism, vol.3, issue.2, pp.177-190, 2014.
DOI : 10.1016/j.molmet.2013.12.009
URL : https://hal.archives-ouvertes.fr/hal-01186418

@. Pedram, A. Razandi, M. , O. Mahony, F. Harvey et al., Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling Prevention of obesity and insulin resistance by estrogens requires eralpha activation function-2 (eralphaaf-2), whereas eralphaaf-1 is dispensable, Sci Signal. Diabetes, vol.662, pp.364098-4108, 2013.

@. Kobayashi, H. Yoshida, S. Sun, Y. Shirasawa, N. Naito et al., Gastric estradiol-17?? (E2) and liver ER?? correlate with serum E2 in the cholestatic male rat, Journal of Endocrinology, vol.301, issue.6, pp.39-49, 2013.
DOI : 10.1152/ajpgi.00061.2011